Evolus Inc (LTS:0K16)
$ 16.611 -0.1026 (-0.62%) Market Cap: 1.04 Bil Enterprise Value: 1.07 Bil PE Ratio: 0 PB Ratio: 53.62 GF Score: 48/100

Q4 2023 Evolus Inc Earnings Call Transcript

Mar 07, 2024 / 09:30PM GMT
Release Date Price: $14.8 (+2.64%)
Operator

Good afternoon, everyone, and thank you for standing by, and welcome to Evolus fourth quarter AM full year 2023 earnings conference call. (Operator Instructions)

I would now like to turn the conference over to Nareg Sagherian, Vice President and Head of Global Investor Relations and Corporate Communications.

Please go ahead.

Nareg Sagherian Evolus
Inc. - Vice President, Head of Global Investor Relations & Corporate Communications

Thank you, operator, and welcome to everyone joining us on today's call to review Atlas's Fourth Quarter and Full Year 2023 financial results.

Our fourth quarter and full year 2023 press release is now on our website at evolus.com. With me today are David Morris, very President and Chief Executive Officer. Rui Avelar, our Chief Medical Officer and Head of R&D, and Sandra Beaver, Chief Financial Officer.

Before we begin our discussion, I'd like to note that during our call, our prepared remarks will include forward-looking statements within the meaning of United States securities laws and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot